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Abstract
Background: No data currently exist about use of antibiotics to prevent surgical site infections
(SSI) among patients undergoing appendectomy in Thailand. We therefore examined risk factors,
use, and efficacy of prophylactic antibiotics for surgical site infection SSI among patients with
uncomplicated open appendectomy.
Methods: From July 1, 2003 to June 30, 2004 we conducted a prospective cohort study in eight
hospitals in Thailand. We used the National Nosocomial Infection Surveillance (NNIS) system
criteria to identify SSI associated with appendectomy. We used logistic regression analysis to obtain
relative risk estimates for predictors of SSI.
Results: Among 2139 appendectomy patients, we identified 26 SSIs, yielding a SSI rate of 1.2
infections/100 operations. Ninety-two percent of all patients (95% CI, 91.0–93.3) received
antibiotic prophylaxis. Metronidazole and gentamicin were the two most common antibiotic
agents, with a combined single dose administered in 39% of cases. In 54% of cases, antibiotic
prophylaxis was administered for one day. We found that a prolonged duration of operation was
significantly associated with an increased SSI risk. Antibiotic prophylaxis was significantly associated
with a decreased risk of SSI regardless of whether the antibiotic was administered preoperatively
or intraoperatively. Compared with no antibiotic prophylaxis, SSI relative risks for combined single-
dose of metronidazole and gentamicin, one-day prophylaxis, and multiple-day antibiotic prophylaxis
were 0.28 (0.09–0.90), 0.30 (0.11–0.88) and 0.32 (0.10–0.98), respectively.
Conclusion: Single-dose combination of metronidazole and gentamicin seems sufficient to reduce
SSIs in uncomplicated appendicitis patients despite whether the antibiotic was administered
preoperatively or intraoperatively.
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Background
Data regarding risk factors and use of antibiotics in surgi-
cal patients are essential for preventing and treating surgi-
cal site infections (SSI). Appendectomy is one of the most
common surgical procedures [1] with SSI complicating 1–
5% of appendectomy cases [2-4]. One established risk fac-
tor for SSI in appendectomy is the duration of operation
[1].
While antibiotic prophylaxis is common in surgical proce-
dures [5], inappropriate use of antibiotics occurs in 25–
50% of general elective surgeries [6-10]. The efficacy of
antibiotic prophylaxis in patients undergoing appendec-
tomy has been examined in several randomized and
observational studies [4,11-19] showing that appropriate
use of antibiotics reduces the risk of SSI following appen-
dectomy by 40–60%.
In Thailand, some hospitals had their own internal antibi-
otic prophylaxis guidelines. However, standardized
national guidelines for antibiotic prophylaxis among
appendectomy patients have not yet been established.
Simple appendicitis is treated according to surgeons' dis-
cretion, which results in use of many different agents.
No study has been conducted of the efficacy of antibiotic
prophylaxis on risk of SSI in patients undergoing appen-
dectomy in Thailand. We aimed to examine risk factors for
SSI, the use of antibiotic prophylaxis, and the efficacy of
antibiotic prophylaxis in reducing SSI among appendec-
tomy patients in Thailand.
Methods
This prospective multicenter cohort study was conducted
from 1 July 2003 to 30 June 2004 in eight Thai hospitals
(four tertiary care teaching hospitals and four geographi-
cally dispersed general hospitals). The participating hospi-
tals were Chiangkham Hospital, Saraburi Hospital,
Bhumibol Adulyadej Hospital, Vachira Phuket Hospital,
Naradhiwas Rajanagarindra Hospital, Rayong Hospital,
Chumphon Khet Udomsakdi Hospital, and Udonthani
Hospital. The project was approved by the Ethical Review
Committee for Research in Human Subjects, the Thai
Ministry of Public Health, and the Ethical Committee
and/or the directors of the participating hospitals. After
attending a one-day training session on data collection
and diagnostic criteria, infection control nurses in each
hospital prospectively collected and recorded data.
Operating room (OR) logbooks were reviewed daily to
identify uncomplicated open appendectomies meeting
the inclusion criteria. We excluded appendectomies inci-
dental to other operative procedures and the patients who
were on antibiotic therapy. Patients' names, hospital
numbers, and wards were identified via OR records. Med-
ical records, operative notes, anesthetic records, diagnos-
tic imaging reports, microbiological and biochemical
data, and data on the operative procedure (duration and
type of operation) were reviewed by study nurses and
attending physicians. The American Society of Anesthesi-
ologists (ASA) score of patient physical status was
abstracted from anesthetic records. Data on the use of
antibiotic prophylaxis included timing of first antibiotic
prophylaxis dose, antibiotic agent, and duration of antibi-
otic therapy. These were obtained from patients' medical
and anesthetic records. Following review, pertinent data
were recorded on preprinted data collection forms.
Outpatient records of discharged patients and medical
records of readmitted patients were also reviewed for evi-
dence of infections developing after hospital discharge.
Completed data collection forms were edited and ana-
lyzed at the study data processing center.
Definitions
We used criteria of the US Centers for Disease Control and
Prevention (CDC) NNIS System to diagnose SSI. Infec-
tions were classified as superficial incisional, deep inci-
sional, or organ/space SSI [20]. The ASA score was used to
characterize the patients' physical status as 1 (healthy), 2
(mild systemic disease), 3 (severe systemic disease), 4
(severe life-threatening systemic disease), or 5 (mori-
bund) [21]. Patients' final diagnoses and operations were
coded according to the International Classification of Dis-
eases 10th Revision (ICD-10) and the International Clas-
sification of Diseases 9th Revision, Clinical Modification
(ICD-9 CM), respectively. The appendectomy procedures
were also classified according to the NNIS [22].
We defined uncomplicated appendicitis as acutely
inflamed appendicitis without perforation (clean-con-
taminated wound). Patients with gangrenous appendici-
tis, peritonitis, or abscess formation were not included.
Statistical analysis
The rate of SSI was computed by dividing the number of
infections by the number of operations performed and
multiplying by one hundred.
Contingency tables were constructed to analyze the rela-
tions between SSI and the other study variables: use and
duration of antibiotic prophylaxis, sex, age, length of pre-
operative stay, type of operation, ASA score, and duration
of operation. We conducted logistic regression analysis to
estimate the relative risk (RR) of SSI for the main study
variables.
All analyses were performed using STATA statistical soft-
ware, version 7 (Stata Corp, College Station, TX).BMC Infectious Diseases 2006, 6:111 http://www.biomedcentral.com/1471-2334/6/111
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Results
Patient and operation characteristics
During the study period, 2139 patients, 53.1% of them
women, underwent open appendectomy. The median age
was 26 years (interquartile range 16 to 39). Twenty-one
percent of patients were hospitalized preoperatively with
a median length of preoperative stay of 1 day (interquar-
tile range 1 to 1). For postoperative or total hospital stay,
median length was 3 days (interquartile range 2 to 4).
Among 2139 operations, 72.4% were classified as emer-
gency. The median operation duration was 58 minutes
(interquartile range 42 to 83).
SSI rates
Twenty-six SSIs were identified in 2139 operations, yield-
ing an overall SSI rate of 1.2 infections/100 operations.
Superficial and deep incisional SSIs occurred most fre-
quently (46.2% each). Of the 26 SSIs, 15 (57.7%) were
detected after hospital discharge, and a half, within seven
days after surgery. The median onset of SSI was 8 days
(interquartile range 5–11).
Risk factors
The following variables were associated with the risk of
SSI in the crude analyses: duration of antibiotic prophy-
laxis, age, elevated ASA score, prolonged preoperative hos-
pital stay, duration of operation, emergency surgery, and
sex. However, after adjustment, only prolonged duration
of operation remained significantly associated with an
increased risk of SSI (RR = 3.29; 95% CI 1.44–7.52) (Table
1).
The use of antibiotic prophylaxis
Prophylactic antibiotics were administered in the course
of 1972/2139 (92.2%) operations. In 89.8% of these
cases, antibiotics were given preoperatively, but they were
given within one hour before the incision in only 38.9%
of cases. The most common prophylactic antibiotics were
metronidazole and gentamicin (64.2%). The combina-
tion of a single dose of metronidazole and gentamicin was
used in 38.8% of cases. Antibiotic prophylaxis was admin-
istered for one day in 54.2% of cases. The median dura-
tion of antibiotic prophylaxis was 1 day (interquartile
range 1 to 2). Antibiotic prophylaxis was extended for
over one day in 38.0% of patients (Table 2).
The doses of antibiotic prophylaxis administrated in this
study were metronidazole 500 mg, gentamicin 80 mg,
penicillin 2 million units, amoxicillin 500 mg, amoxicil-
lin/clavulanate 1.2 g, ampicillin 1 g, cloxacillin 1 g,
cefazolin 1 g, cephalexin 1 g, cefotaxime 1 g, ceftriaxone 2
g, ceftazidime 1 g, cefdinir 100 mg, cefoxitin 1 g, ofloxacin
200 mg, norfloxacin 400 mg, cotrimoxazole 480 mg,
chloramphenical 1 g, fosfomycin 1 g, clindamycin 600
mg, and amikacin 500 mg.
Table 1: The association between selected risk factors and surgical site infections
Risk factors N Infection Rate* Relative risk
Crude 95% CI Adjusted** 95% CI
Duration of 
antibiotic 
prophylaxis
None 167 5 3.0 1.00 Reference 1.00 Reference
1 day 1159 12 1.0 0.34 0.12–0.97 0.30 0.10–0.89
>1 day 813 9 1.1 0.36 0.12–1.09 0.29 0.09–0.92
Duration of 
operation
≤ 1.0 hour 1738 16 0.9 1.00 Reference 1.00 Reference
>1.0 hour 401 10 2.5 2.75 1.24–6.11 3.29 1.44–7.52
Age
1–20 years 808 6 0.7 1.00 Reference 1.00 Reference
21–40 years 853 14 1.6 2.23 0.85–5.83 2.15 0.82–5.68
41–60 years 382 5 1.3 1.77 0.54–5.85 1.91 0.57–6.48
>60 years 96 1 1.0 1.41 0.17–11.81 2.11 0.22–20.76
Type of 
operation
Elective 591 9 1.5 1.00 Reference 1.00 Reference
Emergency 1548 17 1.1 0.72 0.32–1.62 0.78 0.33–1.83
Total 2139 26 1.2 - - - -
* Rate = # infections/100 operations
**Adjusted for sex, age, length of preoperative stay, type of operation, ASA score, and duration of operationBMC Infectious Diseases 2006, 6:111 http://www.biomedcentral.com/1471-2334/6/111
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Efficacy of antibiotic prophylaxis
Antibiotic prophylaxis was associated with decreased risk
of SSI, while timing of administration – preoperatively vs.
intraoperatively – had no effect on risk. Compared with
no antibiotic prophylaxis, receiving one-day, or multiple-
day antibiotic prophylaxis was each associated with about
one third of the SSI risk, adjusted RR were 0.30 (0.11–
0.88) and 0.32 (0.10–0.98), respectively (Table 3). This
reduced risk was also found when receiving only a single
dose of metronidazole in combination with gentamycin
(adjusted RR = 0.28 (0.09–0.90)), Data on duration,
administration time, and antibiotic agent associated with
SSI, adjusted for age, sex, ASA score, and duration of oper-
ation, are shown in Table 3.
Discussion
This prospective cohort study conducted in eight Thai
hospitals showed that a prolonged duration of operation
was a significant risk factor for SSI among patients under-
going appendectomy. Conversely, antibiotic prophylaxis
was inversely related to the risk of SSI in such uncompli-
cated appendicitis patients. Single-day antibiotic prophy-
laxis was found to be as effective as multiple-day
antibiotic prophylaxis in reducing SSIs and administering
prophylaxis before the incision or intraoperatively did not
affect the risk. A combined single dose of metronidazole
and gentamicin seemed sufficient to reduce risk of SSI in
uncomplicated appendicitis patients.
Study strengths and weaknesses
The strengths of this study are its large sample size and
prospective cohort design with complete early follow-up.
Furthermore, we were able to include all patients admit-
ted with uncomplicated appendicitis, who underwent
open surgery in all of the eight hospitals.
Among the study limitations was the failure to account for
differences in surgical technique, preoperative and post-
operative practices. However, appendectomies are per-
formed quite uniformly in Thailand and we consider large
variation in these practices unlikely. Owing to high cost of
post-discharge surveillance, we were unable to follow all
patients for 30 days after surgery. Curtailed follow-up may
cause underestimation of the SSI rate. Still, the SSI rate in
our study (1.2%) was similar to that observed in the NNIS
system report (1.3%) [2]. Some SSIs were potentially mis-
classified when the exact layer of tissue or organ/space
involved in the infection was unclear. To limit such mis-
classification, an expert was consulted in these cases. In
addition, the surgeon and at least one person from the
infection control team had to agree to the diagnosis and
classification of SSI in all cases.
Risk factors
A prolonged duration of operation has been reported as a
risk factor for SSI in other studies [1,23,24]. Earlier inves-
tigations have also reported increasing age [25], and emer-
Table 2: Characteristics of antibiotic prophylaxis administration
Characteristics Number % Infection Rate*
Antibiotic prophylaxis (N = 2139)
No 167 7.8 5 3.0
Yes 1972 92.2 21 1.1
Time of first antibiotic dose administration (N = 1972)
>1 hour preoperatively 1004 50.9 8 0.8
≤ 1 hour preoperatively 767 38.9 9 1.2
Intraoperatively 47 2.4 0 0.0
Postoperatively 154 7.8 4 2.6
Antibiotic agent (N = 1972)
Combination Metronidazole and Gentamicin 1266 64.2 13 1.0
Single dose combination 766 38.8 8 1.0
Combination within 1 day 130 6.6 1 0.8
Combination > 1 day 370 18.8 4 1.1
Others** 706 35.8 8 1.1
Single dose 108 5.5 2 1.9
Multiple dose or combination within 1 day 155 7.9 1 0.6
Combination > 1 day 443 22.4 5 1.1
Duration of antibiotic prophylaxis*** (N = 2139)
None 167 7.8 5 3.0
1 day 1159 54.2 12 1.0
>1 day 813 38.0 9 1.1
* Rate = infections/100 operations
** Others: Penicillin, amoxicillin, amoxicillin/clavulanate, ampicillin, cloxacillin, cefazolin, cephalexin, cefotaxime, ceftriaxone, ceftazidime, cefdinir, 
cefoxitin, ofloxacin, norfloxacin, cotrimoxazole, chloramphenical, fosfomycin, clindamycin, and amikacin.
*** Median = 1 day (interquartile range 1–2 days)BMC Infectious Diseases 2006, 6:111 http://www.biomedcentral.com/1471-2334/6/111
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gency surgery [26] as risk factors of SSI. Our study did not
show substantial association between these factors and
the risk of SSI. Under-accounting for other predictors of
SSI not included in our analysis might explain our failure
to observe an association between age or emergency sur-
gery and SSI.
The use of antibiotic prophylaxis
Twenty-one different antibiotic agents were administered
to appendectomy patients in our study, highlighting the
lack of consensus among Thai surgeons in prescribing
practices. Metronidazole plus gentamicin were most com-
monly used agents, and our study confirmed their effec-
tiveness in reducing SSIs reported by others [18,19]. The
prophylaxis was effective despite the fact that timing of
prophylaxis followed international guidelines in only
39% of the cases [27,28]. This finding corroborates the
notion that the timing of the administration – pre-, intra-
or post-operation – may not be crucial for preventing SSIs
[1]. At the same time, higher SSI rate was reported among
patients who received antibiotic prophylaxis after surgical
incision [29], probably because the antibiotic serum con-
centration at the surgical closure is strongly associated
with SSI [30].
The American Society of Health System Pharmacists
(ASHP) [27] recommends prophylaxis with cepha-
losporins for uncomplicated appendicitis [27,28], with
metronidazole and gentamicin only considered an alter-
native in cases of penicillin allergy. However, the combi-
nation of metronidazole plus gentamicin may have an
economic advantage. A Thai study indicated that the esti-
mated cost for these combined agents was 210 baht per 24
hours, compared with 1160 baht for cefoxitin [31].
Adverse effects were not documented for our patients.
Extended duration of antibiotic prophylaxis was less fre-
quent in our study than in a Malaysian study [32], but our
finding is consistent with other studies conducted in
France [8] and Spain [9].
The improper use of antibiotic agents and inappropriately
prolonged duration of antibiotic prophylaxis are likely to
cause antimicrobial resistance [33-38]. Surgeons and sur-
gical departments need to update their practices of antibi-
otic prophylaxis to comply with standard guidelines
[27,28] and updated evidencebase [1].
Efficacy of antibiotic prophylaxis
Antibiotic prophylaxis is associated with a decreased risk
of postoperative SSIs. This finding is in agreement with
other studies [4,14-19]. In addition, our data indicate that
in uncomplicated appendicitis cases, one-day antibiotic
prophylaxis is just as effective in reducing SSIs as multiple-
day antibiotic prophylaxis. Thus, our study does not offer
justification for routine administration of oral antibiotics
upon hospital discharge as in a previous study [39]. Fur-
thermore, our findings correspond to findings in other
reports [27,40], a single-dose antibiotic [40], such a com-
bined a single dose of metronidazole and gentamicin, was
efficient to reduce SSIs in uncomplicated appendicitis
[27].
Table 3: Association between surgical site infections and duration, timing, and antibiotic prophylaxis agent, adjusted for age, sex, ASA 
score, and duration of operation
Predictor variable N Infection Rate* Relative risk
Crude 95% CI Adjusted** 95% CI
Duration of antibiotic prophylaxis
None 167 5 3.0 1.00 Reference 1.00 Reference
1 day 1159 12 1.0 0.34 0.12–0.97 0.30 0.10–0.88
>1 day 813 9 1.1 0.36 0.12–1.09 0.32 0.10–0.98
Time of first antibiotic dose administration
None 167 5 3.0 1.00 Reference 1.00 Reference
>1 hour preoperatively 1004 8 0.8 0.26 0.08–0.81 0.22 0.07–0.70
≤ 1 hour preoperatively or interoperation 814 9 1.1 0.36 0.12–1.09 0.33 0.11–1.02
Postoperatively 154 4 2.6 0.86 0.23–3.28 0.78 0.20–3.00
Antibiotic agent
None 167 5 3.0 1.00 Reference 1.00 Reference
Single dose combination metronidazole and gentamicin 766 8 1.0 0.34 0.11–1.06 0.28 0.09–0.90
Combination metronidazole and gentamicin within 1 day 130 1 0.8 0.25 0.03–2.18 0.22 0.03–1.98
Combination metronidazole and gentamicin > 1 day 370 4 1.1 0.35 0.09–1.34 0.29 0.08–1.12
Others*** 706 8 1.1 0.37 0.12–1.15 0.37 0.12–1.15
* Rate = infections/100 operations
** Adjusted for age, sex, ASA score, and duration of operation
*** Others: Penicillin, amoxicillin, amoxicillin/clavulanate, ampicillin, cloxacillin, cefazolin, cephalexin, cefotaxime, ceftriaxone, ceftazidime, cefdinir, 
cefoxitin, ofloxacin, norfloxacin, cotrimoxazole, chloramphenical, fosfomycin, clindamycin, and amikacin.BMC Infectious Diseases 2006, 6:111 http://www.biomedcentral.com/1471-2334/6/111
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Conclusion
A prolonged duration of operation was associated with
increased risk of SSI among appendectomy patients, while
antibiotic prophylaxis was associated with decreased risk.
A combined a single dose of metronidazole and gen-
tamicin administered preoperatively or intraoperatively
appears sufficient to reduce SSIs in patients with uncom-
plicated appendicitis. We recommend that preoperative
antibiotic prophylaxis be administered to all patients
undergoing appendectomy.
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